Order results by:
| Issue | Title | |
| Vol 14, No 2 (2021) | Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries | Abstract similar documents |
| A. B. Ismoilova, N. M.U. Sultanbaeva, A. A. Abdurakhmanov, Sh. Z. Umarova, D. Kh. Dzhalalova, S. Ch. Dzhalalov | ||
| "... .43) for staged tactics (p˂0.005). The risk of stroke developing was RR 1.29 (95% CI 0.56–2.99) for a simultaneous ..." | ||
| Vol 8, No 1 (2015) | PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| L. S. Melnikova | ||
| "... The article sets out the results of analysis of existing models of risk sharing agreements, which ..." | ||
| Vol 16, No 2 (2023) | Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow | Abstract similar documents |
| E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova | ||
| "... using drugs based on a comprehensive assessment of risk factors. Material and methods. We used ..." | ||
| Vol 17, No 3 (2024) | Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences | Abstract similar documents |
| E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov | ||
| "... Objective: to assess the demand for pharmacotherapy in risk groups on adverse cardiovascular (CV ..." | ||
| Vol 18, No 1 (2025) | Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms | Abstract similar documents |
| A. V. Vorobеv, A. G. Solopova, V. O. Bitsadze, M. M. Baeva, M. E. Sosnyagova, V. N. Galkin, D. O. Utkin, A. D. Makatsariya | ||
| "... in assessing the risk of venous thromboembolism (VTE) in patients with malignant neoplasms of the female ..." | ||
| Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract similar documents |
| I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
| "... Objective: the development and verification of a scale for identifying patients at high risk ..." | ||
| Vol 14, No 3 (2021) | Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases | Abstract similar documents |
| O. L. Zadvornaya, A. N. Pishchita | ||
| "... Objective: to evaluate behavioral risk factors (BRF) in patients with arterial hypertension (AH ..." | ||
| Vol 14, No 4 (2021) | Machine learning based on laboratory data for disease prediction | Abstract similar documents |
| A. V. Gusev, R. E. Novitskiy, A. A. Ivshin, A. A. Alekseev | ||
| "... medicine based on the calculation of individual risk. There is an increase in the activity of research ..." | ||
| Vol 16, No 1 (2023) | Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program | Abstract similar documents |
| T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina | ||
| "... provision (PDP) program for adult patients at very high cardiovascular (CV) risk, including those who have ..." | ||
| Vol 15, No 4 (2022) | Dietary factors influencing the COVID-19 epidemic process | Abstract PDF (Eng) similar documents |
| S. V. Ponomarenko | ||
| Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
| E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
| Vol 12, No 2 (2019) | Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU | Abstract similar documents |
| G. N. Gildeeva, A. V. Belostotsky | ||
| "... ) and risk management plans (RMP) was also carried out. Results. The united EAEU drug market is a complex ..." | ||
| Vol 7, No 4 (2014) | MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES | Abstract similar documents |
| M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya | ||
| "... » treatment costs of patients who received combined, staged treatment in a neurological hospital ..." | ||
| Vol 12, No 4 (2019) | Clinical and economic analysis of drug costs in a general hospital in 2014-2018 | Abstract similar documents |
| A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova | ||
| "... with a simultaneous analysis of case histories. Results. The analysis of drug purchases in 2014-2018 and the obtained ..." | ||
| Vol 6, No 3 (2013) | METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES | Abstract similar documents |
| R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze | ||
| Vol 13, No 4 (2020) | Concept of value-based healthcare | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov | ||
| Vol 7, No 2 (2014) | THE ANALYSIS OF THE EFFECTIVENESS OF THROMBOPROPHYLAXIS AMONG PREGNANT WOMEN WITH MESENCHYMAL DYSPLASIA | Abstract similar documents |
| E. G. Kudinova, A. P. Momot, N. V. Trukhacheva | ||
| "... dysplasia was carried out. It was concluded that it reduces the risk of thrombohemorrhagic complications ..." | ||
| Vol 11, No 1 (2018) | Medical care of ambulatory patients and its assessment: a review of international experience | Abstract similar documents |
| D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky | ||
| "... in outpatients. General approaches, benefits, risks and other criteria of quality assessment are described. ..." | ||
| Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
| D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
| "... The paper examines the international experience of drug supply and the risks faced by countries ..." | ||
| Vol 15, No 4 (2022) | Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease | Abstract similar documents |
| R. V. Royuk, S. K. Yarovoy, I. B. Shikina | ||
| "... with a simultaneous decrease in the proportion of poly-resistant gram-negative infectious agents (nosocomial strains ..." | ||
| Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract similar documents |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| "... the application dalteparin in comparison with other low-molecular-weight heparins in patients with high risk ..." | ||
| Vol 8, No 2 (2015) | REVIEW OF THE INTERNATIONAL PRACTICE OF COST-SHARING MECHANISM IN NATIONAL HEALTH CARE SYSTEMS | Abstract similar documents |
| Natalia Nikolayevna Sisigina, Vitalii Vladimirovich Omel'yanovskii, Nikolay Alexandrovich Avxentyev | ||
| "... to prevent the risk of patient’s moral hazard. Theoretical background and types of cost-sharing, protection ..." | ||
| Vol 6, No 2 (2013) | FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS | Abstract similar documents |
| A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure | ||
| "... : Existing type 2 DM models were evaluated. Risk equations for type 2 DM complications were compiled ..." | ||
| Vol 9, No 3 (2016) | EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov | ||
| "... . Dabigatran increased major bleeding risk compared to apixaban RR=2.36; 95% CI 1.15-4.82 and the risk major ..." | ||
| Vol 17, No 2 (2024) | Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients – 2024: Council of Experts resolution | Abstract similar documents |
| А. S. Petrikov, Т. V. Vavilova, А. V. Vardanyan, М. N. Zamyatin, I. А. Zolotukhin, К. V. Lobastov, Е. V. Roitman, Е. I. Seliverstov, Yu. М. Stoyko, I. А. Suchkov | ||
| "... practice, discussed risk factors and the frequency of VTE development, including bleeding ..." | ||
| Vol 8, No 2 (2015) | REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS | Abstract similar documents |
| Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev | ||
| "... , risk management, and international rare diseases patient registries could be used to solve ..." | ||
| Vol 17, No 4 (2024) | Biologically active supplements: safety, efficacy, market review | Abstract similar documents |
| A. M. Stepanova, А. N. Plutnitskiy, E. V. Gameeva | ||
| "... and safety of BAS, as well as the market for such products. The presented data underscore the risks ..." | ||
| Vol 5, No 2 (2012) | WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM | Abstract similar documents |
| A. I. Borodin | ||
| "... and inflation generate risks, both for firm, and for its foreign partners. For the purpose of optimum strategy ..." | ||
| Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
| D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
| "... alternative for patients with highly active MS and patients with a high risk of progressive multifocal ..." | ||
| Vol 14, No 1 (2021) | Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. S. Sardaryan, T. E. Bogacheva, T. R. Grishina, I. V. Gogoleva, O. A. Limanova, O. A. Gromova | ||
| "... to an extreme increase in the risk of OA (OR 56.3, 95% CI 17.4–181.6, p<10–20). Analysis of the 62 elements ..." | ||
| Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
| V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
| "... payments, risk-sharing agreements, and their combinations. Still, none of these payment methods ..." | ||
| Vol 13, No 1 (2020) | Health technology assessment in obstetrics: advantage of tailored conservative strategy vs surgical therapies of monochorionic twin complicated by TRAP-sequence | Abstract similar documents |
| V. I. Tsibizova, I. E. Govorov, I. I. Averkin, N. M. Khamani, D. V. Blinov | ||
| "... risk, may lead to an unreasonable increase in surgical interventions. In turn, surgery is not only ..." | ||
| Vol 14, No 4 (2021) | Application of medical products: mandatory requirements, supervision of their compliance | Abstract similar documents |
| O. A. Makhova | ||
| "... of a risk-oriented approach to conducting scheduled inspections since 2018, the introduction of a mechanism ..." | ||
| Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract similar documents |
| O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
| "... transplantation. We evaluated the particularly dangerous moderate interactions that pose the greatest risk ..." | ||
| Vol 8, No 4 (2015) | ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS | Abstract similar documents |
| A. N. Korobeynikova, S. V. Malchikova | ||
| "... in practice, leading to an increased risk of death, stroke, heart failure. The results of pharmacoeconomical ..." | ||
| Vol 10, No 3 (2017) | Decision modelling for the evaluation of diabetes outcomes | Abstract similar documents |
| A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin | ||
| "... , empagliflozin) capable of significantly reducing cardiovascular risks in DM patients, require new approaches ..." | ||
| Vol 11, No 4 (2018) | Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease | Abstract similar documents |
| V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev | ||
| "... of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular ..." | ||
| Vol 12, No 3 (2019) | Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia | Abstract similar documents |
| V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina | ||
| "... obstacles and risks for their implementation. Materials and methods. We reviewed documents and publications ..." | ||
| Vol 14, No 2 (2021) | Systematic computer analysis of published literature on nutritional support for vaccination | Abstract similar documents |
| A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova | ||
| "... feasible and reduces the vaccination risks for patients with polyhypoavitaminoses. ..." | ||
| Vol 14, No 1 (2021) | Review of foreign experience in the implementation of eHealth | Abstract similar documents |
| P. V. Minaev, D. V. Fedyaev, Yu. V. Seryapina, T. V. Skomorokhova | ||
| "... -border eHealth and the use of quality management tools for medical activities to reduce risks when ..." | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
| M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
| "... against COVID-19 with a high risk of progression to severe COVID-19. Effectiveness and safety ..." | ||
| Vol 16, No 4 (2023) | Legal particularities of AI technology usage in real-world data formation | Abstract similar documents |
| V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya | ||
| "... essential risks of human rights restriction, it may also form discriminatory practices or even cause harm ..." | ||
| Vol 17, No 3 (2024) | Biologically active supplements overview: regulation, market trends, application, and health impact | Abstract similar documents |
| A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva | ||
| "... and treatment of this new disease to strengthen the immune system and minimize the risk of possible ..." | ||
| Vol 18, No 1 (2025) | Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients | Abstract similar documents |
| M. E. Mantsaeva, D. I. Korabelnikov, A. G. Borisov | ||
| "... in response to gluten. In the main group, the risk of a 50% decrease in the estimated glomerular filtration ..." | ||
| Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract similar documents |
| I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
| "... risk factor for poor prognosis in stable angina. The aim of the research: assessment of the economic ..." | ||
| Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract similar documents |
| N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
| "... ) the inflation risks in the period until 2020. Results. The comparison of different clinical studies ..." | ||
| Vol 10, No 1 (2017) | THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT | Abstract similar documents |
| V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova | ||
| "... . A set of measures preventing these risk factors from converting into full-scale disease is needed. ..." | ||
| Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
| "... - by 1 g/day was associated with a significant decrease in the risk of mortality by an average of 5 ..." | ||
| Vol 15, No 2 (2022) | Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis | Abstract similar documents |
| O. S. Mikhaylova, A. V. Krikova | ||
| "... the development of risk factors for such serious cardiovascular complications as stroke and myocardial infarction ..." | ||
| Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
| "... , with fibrotic changes in the respiratory tracts and, as well, help to reduce the risk of neoplastic diseases ..." | ||
| 1 - 50 of 59 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
